METAFORA biosystems
Description
METAFORA is developing METAflow, an AI cloud-based software for Single Cell data analysis. Single Cell analysis market is blooming, with the development of new technologies to dive into the complexity of biology. Many applications in life sciences and in diagnostics are relying on these platforms. Still, data analysis is becoming a critical bottleneck. METAflow is a highly differentiating approach to modern Single Cell analysis, addressing multiple market segments from research to clinical diagnostics. Hard launch of a research use only version for flow cytometry is ongoing, with first sales to academics and industrial players under a SaaS business model. Traction is coming from different players in different market segments, witnessing the appetite for such a solution. Ongoing developments allow to propel the growth of the company by positioning the platform on the clinical diagnostics markets, and for the analysis of other Single Cell data (OMICS).
METAFORA is an EIC Accelerator programme winner, and is looking for an investor to join the EIC Fund's investment in the company.
